Young biotech innovators are tackling maternal mortality, brain implants, and genetic diseases
MIT Technology Review's 35 Innovators Under 35 includes nine biotech pioneers. Among them, Paschal Kija created a low-cost device to stop postpartum bleeding, Xiao Yang designs flexible brain electrodes inspired by kirigami, and Sarah Grandinette helped develop a personalized gene-editing therapy for a rare disorder. These efforts aim to save lives and reverse aging.
Kija's low-cost wrap directly addresses a leading cause of maternal mortality in Tanzania. Yang's flexible, kirigami-inspired electrodes are designed to reduce physical trauma to brain tissue. Grandinette's personalized gene-editing approach for KJ involved extensive screening and animal testing before clinical application.
Lu's cellular reprogramming research, initially proven in mice, has advanced to human trials for vision restoration. King's AI-designed bacteriophages successfully demonstrated self-replication and bacterial infection, hinting at future environmental or pharmaceutical uses. These five represent a portion of the nine biotech innovators recognized this year.
These breakthroughs could significantly alter healthcare accessibility and outcomes. Kija's device may drastically reduce maternal deaths in regions lacking advanced medical infrastructure. Yang's electrodes could enable safer neurological monitoring, while Grandinette's therapy might pave the way for personalized rare-disease treatments. Lu's reprogramming tech may eventually address age-related degeneration, and King's AI viruses could offer novel bioremediation or drug delivery methods, though all remain in early stages.